Global Monoclonal Antibodies Market 2021-2025

Published: March 1, 2021 |

TechNavio (Infiniti Research Ltd.) | 120 Pages | Delivery time: 1-2 business days

Price

Description
Table of Contents

Add to Compare

Technavio has been monitoring the monoclonal antibodies market and it is poised to grow by $ 63.41 bn during 2021-2025 progressing at a CAGR of 8% during the forecast period. Our report on monoclonal antibodies market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the introduction of low-priced biosimilar monoclonal antibodies and targeted therapeutic mechanism of action. In addition, introduction of low-priced biosimilar monoclonal antibodies is anticipated to boost the growth of the market as well.

The monoclonal antibodies market analysis includes application segment and geographical landscapes.

Technavio's monoclonal antibodies market is segmented as below:

By Application

Oncology
Autoimmune disorders
Infectious diseases
Other applications

By Geographical Landscapes

North America
Europe
Asia
ROW

This study identifies the strong R&D pipeline as one of the prime reasons driving the monoclonal antibodies market growth during the next few years.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on monoclonal antibodies market covers the following areas:

Monoclonal antibodies market sizing
Monoclonal antibodies market forecast
Monoclonal antibodies market industry analysis

Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading monoclonal antibodies market vendors that include AbbVie Inc., AstraZeneca Plc, Bristol-Myers Squibb Co., F. Hoffmann-La Roche Ltd., GlaxoSmithKline Plc, Johnson & Johnson, Merck & Co. Inc., Novartis AG, Pfizer Inc., and Sanofi SA. Also, the monoclonal antibodies market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast an accurate market growth.